Skip to content
HowShorted

Tvardi Therapeutics, Inc. short interest in 2021

In 2021, Tvardi Therapeutics, Inc.'s disclosed short interest ran from 7.19% of shares outstanding on 15 Jan 2021 to 3.50% on 31 Dec 2021, a change of -3.69 percentage points. The year's high was 7.76% on 30 Apr 2021 and its low 3.50% on 31 Dec 2021, averaging 5.90% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.91 days on 15 Jul 2021. Full history: Tvardi Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Tvardi Therapeutics, Inc. in 2021

2021 in figures

Start of year
7.19% (15 Jan 2021)
End of year
3.50% (31 Dec 2021)
Change
-3.69 pp
High
7.76% (30 Apr 2021)
Low
3.50% (31 Dec 2021)
Average
5.90%
Highest days to cover
8.91 (15 Jul 2021)
SEC filings marked
8

Every report in 2021

Tvardi Therapeutics, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20217.19%8.82
29 Jan 20215.87%5.62
12 Feb 20215.62%4.89
26 Feb 20216.16%7.0510-K filed, results (8-K)
15 Mar 20216.45%7.37
31 Mar 20215.49%7.00
15 Apr 20217.19%1.21
30 Apr 20217.76%2.41
14 May 20217.14%3.0910-Q filed, results (8-K)
28 May 20216.28%7.46
15 Jun 20217.08%6.77
30 Jun 20216.34%4.38
15 Jul 20216.09%8.91
30 Jul 20216.09%7.47
13 Aug 20215.97%3.6410-Q filed, results (8-K)
31 Aug 20217.72%1.00
15 Sep 20216.07%3.61
30 Sep 20214.24%3.49
15 Oct 20214.22%4.69
29 Oct 20215.78%2.51
15 Nov 20214.63%3.1910-Q filed, results (8-K)
30 Nov 20214.83%3.78
15 Dec 20213.87%4.08
31 Dec 20213.50%3.65

See also: Tvardi Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.